Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes Zuber

Showing results (111-120 of 169) with videos related to

Pageof 17
Sort By:
Nature Chemical Biology|August 5, 2020
Rational discovery of molecular glue degraders via scalable chemical profilingCristina Mayor-Ruiz, Sophie Bauer, Matthias Brand, et al.
Nature|October 29, 2021
AKIRIN2 controls the nuclear import of proteasomes in vertebratesMelanie de Almeida, Matthias Hinterndorfer, Hanna Brunner, et al.
American Journal of Hematology|July 7, 2022
BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph<sup>+</sup> chronic myeloid leukemiaBarbara Peter, Gregor Eisenwort, Irina Sadovnik, et al.
Blood|October 8, 2025
MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemiaDorien Pastoors, Marije Havermans, Roger Mulet-Lazaro, et al.
Nature Communications|May 19, 2025
Transcriptional and epigenetic rewiring by the NUP98::KDM5A fusion oncoprotein directly activates CDK12Selina Troester, Thomas Eder, Nadja Wukowits, et al.
Journal of Hepatology|March 11, 2023
MYC determines lineage commitment in KRAS-driven primary liver cancer developmentLuana D'Artista, Athina Anastasia Moschopoulou, Iros Barozzi, et al.
Genes & Development|June 19, 2014
Pax5 loss imposes a reversible differentiation block in B-progenitor acute lymphoblastic leukemiaGrace J Liu, Luisa Cimmino, Julian G Jude, et al.
Nature|January 18, 2019
Human blood vessel organoids as a model of diabetic vasculopathyReiner A Wimmer, Alexandra Leopoldi, Martin Aichinger, et al.
Nature Communications|May 20, 2018
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrityAnna Skucha, Jessica Ebner, Johannes Schmöllerl, et al.
Nature Medicine|September 14, 2014
In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancerRamona Rudalska, Daniel Dauch, Thomas Longerich, et al.
Pageof 17

Showing results (111-120 of 169) with videos related to

Sort By:
Pageof 17
Nature Chemical Biology|August 5, 2020
Rational discovery of molecular glue degraders via scalable chemical profilingCristina Mayor-Ruiz, Sophie Bauer, Matthias Brand, et al.
Nature|October 29, 2021
AKIRIN2 controls the nuclear import of proteasomes in vertebratesMelanie de Almeida, Matthias Hinterndorfer, Hanna Brunner, et al.
American Journal of Hematology|July 7, 2022
BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph<sup>+</sup> chronic myeloid leukemiaBarbara Peter, Gregor Eisenwort, Irina Sadovnik, et al.
Blood|October 8, 2025
MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemiaDorien Pastoors, Marije Havermans, Roger Mulet-Lazaro, et al.
Nature Communications|May 19, 2025
Transcriptional and epigenetic rewiring by the NUP98::KDM5A fusion oncoprotein directly activates CDK12Selina Troester, Thomas Eder, Nadja Wukowits, et al.
Journal of Hepatology|March 11, 2023
MYC determines lineage commitment in KRAS-driven primary liver cancer developmentLuana D'Artista, Athina Anastasia Moschopoulou, Iros Barozzi, et al.
Genes & Development|June 19, 2014
Pax5 loss imposes a reversible differentiation block in B-progenitor acute lymphoblastic leukemiaGrace J Liu, Luisa Cimmino, Julian G Jude, et al.
Nature|January 18, 2019
Human blood vessel organoids as a model of diabetic vasculopathyReiner A Wimmer, Alexandra Leopoldi, Martin Aichinger, et al.
Nature Communications|May 20, 2018
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrityAnna Skucha, Jessica Ebner, Johannes Schmöllerl, et al.
Nature Medicine|September 14, 2014
In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancerRamona Rudalska, Daniel Dauch, Thomas Longerich, et al.
Pageof 17